Bristol-Myers Squibb Announces Humacao Site Expansion
Bristol-Myers Squibb Company (NYSE: BMY) today announced a $165 million expansion of its facility in Humacao to add manufacturing capacity that will prepare the plant for the production of additional medicines. The project is expected to create 100 full-time jobs at the facility over time.
“This significant investment in our Humacao facility supports the company’s mission of delivering innovative medicines that help patients prevail over serious diseases,” said Ricardo Zayas, senior vice president, Pharmaceutical Manufacturing, Bristol-Myers Squibb. “Puerto Rico’s highly skilled workforce has contributed significantly to our existing operation and plays an important role in our company’s future growth.”
See full article: